Loading
Latest filing published 06 Dec 2022 for Yumanity Therapeutics, INC., €3,174. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Marie Epstein, listed as senior executive, appears in our data through filings on Kineta, Inc./de shares, published by SEC (Form 4). We count 3 filings; the first trade dates from 1 December 2021 and the latest from 2 December 2022.
The open-market record consists of 2 sales worth €5,180, with no purchase. Besides market trades, the filings include 1 share grant. Since January 2022: no purchases and 2 sales on the market.
On 6 December 2022 came the latest disclosure, an open-market sale for €3,174 in Kineta, Inc./de. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations